IGF2BP2 Overexpression Indicates Poor Survival in Patients with Acute Myelocytic Leukemia
Conclusion: Thus, IGF2BP2 may serve as a biomarker to predict the prognosis of AML and as a potential target in AML.Cell Physiol Biochem 2018;51:1945 –1956
Source: Cellular Physiology and Biochemistry - Category: Cytology Source Type: research
More News: Acute Leukemia | Biochemistry | Cancer | Cancer & Oncology | Cytology | Databases & Libraries | Genetics | Leukemia | Physiology | Study